View Information Collection Request (ICR) Package

OMB Control No: 0920-0978	ICR Reference No: 202204-0920-008
Status: Historical Active	Previous ICR Reference No: 202112-0920-010
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-0978
Title: Emerging Infections Program
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 02/08/2023
Retrieve Notice of Action (NOA)	Date Received in OIRA: 04/25/2022
Terms of Clearance: Approval is consistent with the understanding that CDC will continue to add (and keep current) language on each program's website and in their reports that clearly caveats the interpretation of longitudinal trends due to temporal changes in methods, definitions, geographic coverage (for example, changes in the number and characteristics of participating hospitals).

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2026	36 Months From Approved	02/28/2023
Responses	132,520	0	99,360
Time Burden (Hours)	53,784	0	38,810
Cost Burden (Dollars)	0	0	0

Abstract: The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This Revision requests the use of two additional forms and including minor revised language and rewording to improve clarity and readability of the data collection forms. Programs covered by this ICR include: Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases; Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases; Influenza: active population-based surveillance for laboratory confirmed influenza-related hospitalizations; and Healthcare Associated Infections-Community Interface (HAIC): active population-based surveillance for healthcare associated pathogens and infections (including Clostridium difficile infection).

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 4891	01/31/2022
30-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 24305	04/25/2022
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	132,520	99,360	33,160
Annual Time Burden (Hours)	53,784	38,810	14,974
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Three new forms were added and a couple minor adjustments/corrections to burden or respondents.

Annual Cost to Federal Government: $36,032,895

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Kevin Joyce 404 639-1944 kdj7@cdc.gov

View ICR - OIRA Conclusion